The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
Identifieur interne : 000169 ( PubMed/Corpus ); précédent : 000168; suivant : 000170The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
Auteurs : Aleksandar. Risti ; Nikola Vojvodi ; Slavko Jankovi ; Aleksandra Sindeli ; Dragoslav SokiSource :
- Epilepsia [ 0013-9580 ] ; 2006.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Anticonvulsants (adverse effects), Anticonvulsants (therapeutic use), Cognition Disorders (chemically induced), Cognition Disorders (epidemiology), Drug Administration Schedule, Drug Therapy, Combination, Epilepsy (classification), Epilepsy (diagnosis), Epilepsy (drug therapy), Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (epidemiology), Prevalence, Severity of Illness Index, Treatment Outcome, Valproic Acid (adverse effects), Valproic Acid (therapeutic use).
- MESH :
- chemical , adverse effects : Anticonvulsants, Valproic Acid.
- chemical , therapeutic use : Anticonvulsants, Valproic Acid.
- chemically induced : Cognition Disorders, Parkinson Disease, Secondary.
- classification : Epilepsy.
- diagnosis : Epilepsy.
- drug therapy : Epilepsy.
- epidemiology : Cognition Disorders, Parkinson Disease, Secondary.
- Adolescent, Adult, Aged, Drug Administration Schedule, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Prevalence, Severity of Illness Index, Treatment Outcome.
Abstract
We report the frequency of parkinsonism and cognitive decline (P/CD) in patients treated with valproate (VPA) after 1 year of treatment and at least 1 year of follow-up.
DOI: 10.1111/j.1528-1167.2006.00711.x
PubMed: 17201721
Links to Exploration step
pubmed:17201721Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.</title>
<author><name sortKey="Risti, Aleksandar J" sort="Risti, Aleksandar J" uniqKey="Risti A" first="Aleksandar" last="Risti">Aleksandar. Risti</name>
<affiliation><nlm:affiliation>Institute of Neurology, Clinical Center of Serbia, Belgrade, Serbia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vojvodi, Nikola" sort="Vojvodi, Nikola" uniqKey="Vojvodi N" first="Nikola" last="Vojvodi">Nikola Vojvodi</name>
</author>
<author><name sortKey="Jankovi, Slavko" sort="Jankovi, Slavko" uniqKey="Jankovi S" first="Slavko" last="Jankovi">Slavko Jankovi</name>
</author>
<author><name sortKey="Sindeli, Aleksandra" sort="Sindeli, Aleksandra" uniqKey="Sindeli A" first="Aleksandra" last="Sindeli">Aleksandra Sindeli</name>
</author>
<author><name sortKey="Soki, Dragoslav" sort="Soki, Dragoslav" uniqKey="Soki D" first="Dragoslav" last="Soki">Dragoslav Soki</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="doi">10.1111/j.1528-1167.2006.00711.x</idno>
<idno type="RBID">pubmed:17201721</idno>
<idno type="pmid">17201721</idno>
<idno type="wicri:Area/PubMed/Corpus">000169</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.</title>
<author><name sortKey="Risti, Aleksandar J" sort="Risti, Aleksandar J" uniqKey="Risti A" first="Aleksandar" last="Risti">Aleksandar. Risti</name>
<affiliation><nlm:affiliation>Institute of Neurology, Clinical Center of Serbia, Belgrade, Serbia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vojvodi, Nikola" sort="Vojvodi, Nikola" uniqKey="Vojvodi N" first="Nikola" last="Vojvodi">Nikola Vojvodi</name>
</author>
<author><name sortKey="Jankovi, Slavko" sort="Jankovi, Slavko" uniqKey="Jankovi S" first="Slavko" last="Jankovi">Slavko Jankovi</name>
</author>
<author><name sortKey="Sindeli, Aleksandra" sort="Sindeli, Aleksandra" uniqKey="Sindeli A" first="Aleksandra" last="Sindeli">Aleksandra Sindeli</name>
</author>
<author><name sortKey="Soki, Dragoslav" sort="Soki, Dragoslav" uniqKey="Soki D" first="Dragoslav" last="Soki">Dragoslav Soki</name>
</author>
</analytic>
<series><title level="j">Epilepsia</title>
<idno type="ISSN">0013-9580</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Anticonvulsants (adverse effects)</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Cognition Disorders (chemically induced)</term>
<term>Cognition Disorders (epidemiology)</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Epilepsy (classification)</term>
<term>Epilepsy (diagnosis)</term>
<term>Epilepsy (drug therapy)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Parkinson Disease, Secondary (epidemiology)</term>
<term>Prevalence</term>
<term>Severity of Illness Index</term>
<term>Treatment Outcome</term>
<term>Valproic Acid (adverse effects)</term>
<term>Valproic Acid (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anticonvulsants</term>
<term>Valproic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticonvulsants</term>
<term>Valproic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cognition Disorders</term>
<term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Epilepsy</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Epilepsy</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Epilepsy</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cognition Disorders</term>
<term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Severity of Illness Index</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report the frequency of parkinsonism and cognitive decline (P/CD) in patients treated with valproate (VPA) after 1 year of treatment and at least 1 year of follow-up.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">17201721</PMID>
<DateCreated><Year>2007</Year>
<Month>01</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2007</Year>
<Month>01</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0013-9580</ISSN>
<JournalIssue CitedMedium="Print"><Volume>47</Volume>
<Issue>12</Issue>
<PubDate><Year>2006</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Epilepsia</Title>
<ISOAbbreviation>Epilepsia</ISOAbbreviation>
</Journal>
<ArticleTitle>The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.</ArticleTitle>
<Pagination><MedlinePgn>2183-5</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We report the frequency of parkinsonism and cognitive decline (P/CD) in patients treated with valproate (VPA) after 1 year of treatment and at least 1 year of follow-up.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Three hundred sixty-four patients with various epileptic syndromes and seizure types were treated with VPA mono- or polytherapy for more than 1 year.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We found five cases of P/CD (1.37%; 95% CI, 0.18-2.56%). Among 140 patients with different adverse effects (AEs) of VPA, P/CD were among the rarest in frequency but significant in terms of drug discontinuation (five of 17).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Early identification of this type of AE and discontinuation of the drug led to complete recovery in affected patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ristić</LastName>
<ForeName>Aleksandar J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo><Affiliation>Institute of Neurology, Clinical Center of Serbia, Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vojvodić</LastName>
<ForeName>Nikola</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Janković</LastName>
<ForeName>Slavko</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sindelić</LastName>
<ForeName>Aleksandra</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sokić</LastName>
<ForeName>Dragoslav</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Epilepsia</MedlineTA>
<NlmUniqueID>2983306R</NlmUniqueID>
<ISSNLinking>0013-9580</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>614OI1Z5WI</RegistryNumber>
<NameOfSubstance UI="D014635">Valproic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004334">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010302">Parkinson Disease, Secondary</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014635">Valproic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>1</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">EPI711</ArticleId>
<ArticleId IdType="doi">10.1111/j.1528-1167.2006.00711.x</ArticleId>
<ArticleId IdType="pubmed">17201721</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000169 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000169 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:17201721 |texte= The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17201721" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
![]() | This area was generated with Dilib version V0.6.19. | ![]() |